Dr. Rumi Khan Joins Orlando Health and Sleep Medicine Specialists

Posted on May 23, 2012 by john

Rumi Ahmed Khan, M.D., FCCP has joined Orlando Health’s Critical Care Group and the newly formed Pulmonary and Sleep Medicine Specialists .Dr. Khan holds five board certifications in Internal Medicine, Pulmonary Diseases, Critical Care, Neurocritical Care and Hospice and Palliative Care.

Dr. Khan joins Orlando Health after serving five years as an Assistant Professor  and Director of the Divisional Lung Cancer Collaborative Program at the Medical College of Wisconsin (MCW) and Zablocki Veterans Administration Medical Center in Milwaukee. During that time, he was also Director of the Smoking Cessation Program at Clinical Cancer Center. As part of the faculty of the cancer center, he developed a lung cancer program which included screening, diagnostic work-up and follow up with patients undergoing lung resections and chemotherapy.

Dr. Khan’s academic and clinical experience will be well utilized as a pulmonary critical care faculty physician and at Orlando Regional Medical Center (ORMC) and MD Anderson Cancer Center – Orlando. He is also an Associate Professor, Department of Medicine at the University of Central Florida College of Medicine and Adjunct Faculty at the University of Florida.

After completing his medical degree at Chittagong Medical College at the University of Chittagong in Bangladesh, Dr. Khan received a Post-Doctoral Fellowship in molecular biology and genetics and basic sciences at Wayne State University (WSU)School of Medicine in Detroit. This was followed by his residency in internal medicine at Mt. Sinai School of Medicine and Queens Hospital Center in New York. He returned to WSU School of Medicine to complete a fellowship in Pulmonary Critical Care and Sleep Medicine and served as Chief Fellow during his final year. He was one of only six fellows in the country to be awarded the Glaxo Smith Kline Pulmonary Fellowship Award and Research Grant in 2004-5.

His clinical and research focus has involved Critical Care, General Pulmonology, Pulmonary Hypertension as well as a collaborative approach to lung nodules, cancer diagnosis and management. Dr Khan took particular interest in   radon awareness in prevention of Lung Cancer. He notes significant progress in the past 10-12 years in offering a variety of medications to patients with pulmonary hypertension, making a huge impact on the quality of life of these patients. Dr. Khan initially focused his research on the role of epidermal growth factor receptors (EGFR) and their potential role in treating lung cancer.

Dr. Khan will be seeing in-patients on our newly formed Pulmonary Service at the Orlando Health Pulmonology and Sleep Medicine Specialists practice with four attending pulmonologists available to see out-patients at 21 West Columbia Street, 2^nd Floor. Referrals may be made by calling 321-841-PULM (7856).